Ceres Ventures, Inc. (CEVE)
Ceres Ventures, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $8,550. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of -101.80 implies it has historically moved less than the broad market.
Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air. The company's core technological offerings comprise: BluFlow Nanoparticles: A proprietary system that engineers and deploys tailor-made absorbent nanoparticles. These microscopic particles are designed to precisely capture and remove various contaminants and chemicals, and can also be utilized to recover valuable elements and compounds from aquatic environments. BluFlow Advanced Ultrafiltration Technology: An automated ultrafiltration process focused on reclaiming clean water from industrial waste streams and other impure liquid sources. The BluFlow Treatment System, which integrates both the Nanoparticle and Advanced Ultrafiltration technologies. This comprehensive solution effectively eliminates a broad spectrum of pollutants, compounds, and undesirable elements, rendering water sufficiently pure for potential reuse. These solutions find diverse applications, including municipal and industrial water and wastewater purification, remediation of tainted groundwater, and the extraction of valuable resources from various solutions. Previously operating as PhytoMedical Technologies, Inc., the company adopted its current name, Ceres Ventures, Inc., in November 2011. Its headquarters are located in New York, New York.
Ceres Ventures, Inc. is most often compared with the following Healthcare names: